FineImmu
泛恩生物
FineImmu
Biotech/Healthcare
Guangzhou Fann Biotechnology Co., Ltd. takes conquering cancer as its mission, aiming to provide efficient tumor treatment solutions and improve patients' cure rates and quality of life.
Latest round: Series A (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.